Visit our news section for more articles.
News Our full Mednous news archive Appointments Latest industry appointments Events A list of upcoming industry events
Evernow Publishing Ltd Privacy Policy. Read more.
Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.
The latest MedNous journal. Subscribe to download.
Netherlands
The venture capital firm Forbion has announced a large financing for one of its portfolio companies, NewAmsterdam Pharma BV, which is planning Phase 3 development of a cholesterol lowering drug for patients who aren’t well controlled on statins. The oversubscribed €160 million Series A round was led by Forbion and co-led by Morningside Ventures and Ascendant BioCapital.
France
Sanofi SA is to acquire Kymab Ltd of the UK in order to gain full rights to a monoclonal antibody therapy, KY1005, with potential for treating a wide variety of immune-mediated and inflammatory disorders. The French pharma group is to pay $1.1 billion upfront for the company in addition to milestone payments of up to $350 million. The lead asset reported positive data from a Phase 2a study of patients with atopic dermatitis in August 2020. The same molecule is being studied in acute graft-vs-host disease and other immune disorders.
Netherlands
The European Commission has granted a conditional marketing authorisation for a Covid-19 vaccine developed by Moderna Inc based on clinical data showing an efficacy rate of 94.1%. The vaccine, COVID-19 Vaccine Moderna, is to be administered to people from 18 years of age. It is the second Covid-19 vaccine to be approved by the EU following a recommendation by the European Medicines Agency. The first was a vaccine developed by BioNTech SE and Pfizer Inc. Both vaccines are based on messenger RNA (mRNA) technology.
United States
Italy
United Kingdom
United States
United States
Netherlands
Belgium
Japan
United States
Belgium
Visit our news section for more articles.
News Our full Mednous news archive Appointments Latest industry appointments Events A list of upcoming industry events
© 2021 Evernow Publishing Ltd. Powered by Drupal.